VivoSeq
Other

Postoperative Pain Management

0

Pipeline Programs

10

Active Trials

1

Companies Involved

Postoperative Pain Management is an early-stage landscape with 0 programs across 1 company. The most active players are Shanghai Yidian Pharmaceutical Technology Development Co., Ltd..

Pipeline Metrics

Competitive Density

27/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

6/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

51

clinical trials

Completed25 · 49%
Unknown status13 · 25%
Recruiting5 · 10%
Not yet recruiting3 · 6%
Withdrawn3 · 6%
Active, not recruiting2 · 4%

Trial Activity

51 trials

Postoperative Pain Management in Laparoscopic Cholecystectomies
Active, not recruiting··N/A·NCT06326281·100 enrolled
Postoperative Pain Management on Patients Undergoing Lung Tumor Resection
Not yet recruiting··N/A·NCT06397807·400 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)